In an effort to promote the Immunoscore in routine clinical settings, an international task force was initiated. This review represents a follow-up of the announcement of this initiative, and of the J Transl Med. editorial from January 2012. Immunophenotyping of tumors may provide crucial novel prognostic information. The results of this international validation may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM-I (TNM-Immune).
Authors: Jérôme Galon, Franck Pagès, Francesco M. Marincola, Helen K. Angell, Magdalena Thurin, Alessandro Lugli, Inti Zlobec, Anne Berger, Carlo Bifulco, Gerardo Botti, Fabiana Tatangelo, Cedrik M. Britten, Sebastian Kreiter, Lotfi Chouchane, Paolo Delrio, Hartmann Arndt, Martin Asslaber, Michele Maio, Giuseppe V. Masucci, Martin Mihm, Fernando Vidal-Vanaclocha, James P. Allison, Sacha Gnjatic, Leif Hakansson, Christoph Huber, Harpreet Singh-Jasuja, Christian Ottensmeier, Heinz Zwierzina, Luigi Laghi, Fabio Grizzi, Pamela S. Ohashi, Patricia A. Shaw, Blaise A. Clarke, Bradly G. Wouters, Yutaka Kawakami, Shoichi Hazama, Kiyotaka Okuno, Ena Wang, Jill O'Donnell-Tormey, Christine Lagorce, Graham Pawelec, Michael I. Nishimura, Robert Hawkins, Réjean Lapointe, Andreas Lundqvist, Samir N. Khleif, Shuji Ogino, Peter Gibbs, Paul Waring, Noriyuki Sato, Toshihiko Torigoe, Kyogo Itoh, Prabhu S. Patel, Shilin N. Skukla, Richard Palmqvist, Iris D. Nagtegaal, Yili Wang, Corrado D'Arrigo, Scott Kopetz, Frank A. Sinicrope, Giorgio Trinchieri, Thomas F. Gajewski, Paolo A. Ascierto and Bernard A. Fox
Published as a review in the Journal of Translational Medicine (2012) 10: 205.
#SITCPublication